The FDA has approved veligrotug-vvze (Lumvoa) for the treatment of thyroid eye disease regardless of disease activity or duration, based on the pivotal phase 3 THRIVE and THRIVE-2 clinical trials.
A nationwide target trial emulation in US veterans with type 2 diabetes found that semaglutide initiation was associated with a twofold increased risk of nonarteritic anterior ischemic optic neuropathy...
A cross-sectional study of Thai women aged 41 to 60 years found that nearly two-thirds experienced dry eye symptoms, with comparable rates across peri- and postmenopausal groups. Computer-based work...
Researchers systematically reviewed 21 studies with more than 400,000 participants to determine any associations between dry eye disease and sleep quality.
Researchers examined the efficacy of allogeneic adipose-derived mesenchymal stem cell injections into the lacrimal gland for treating dry eye disease in patients with Sjögren syndrome.
Researchers sought to determine if the use of re-esterified triglyceride ω-3 fatty acid was effective in treating dry eye disease associated with meibomian gland dysfunction.
The development of new treatment options for nephropathic cystinosis has resulted in a higher likelihood of survival to adulthood for these patients but has also introduced new challenges in management....
Researchers examined the efficacy of a sutureless dehydrated amniotic membrane under a specialized bandage contact lens for the treatment of dry eye disease.
